Literature DB >> 28616121

New research in prostate cancer, ASCO-GU 2017.

Kim Chi1, Fred Saad2.   

Abstract

Entities:  

Year:  2017        PMID： 28616121      PMCID： PMC5461155          DOI： 10.5489/cuaj.4608

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  1 in total

1.  Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy-naïve castration-resistant prostate cancer: The Kyoto-Baltimore collaboration.

Authors:  Naoki Terada; Benjamin L Maughan; Shusuke Akamatsu; Takashi Kobayashi; Toshinari Yamasaki; Takahiro Inoue; Tomomi Kamba; Osamu Ogawa; Emmanuel S Antonarakis
Journal:  Int J Urol       Date:  2017-04-28       Impact factor: 3.369
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.